Tsung-ying T. Yang
No. 1650, Sect. 4, Taiwan Boulevard, 407
Taitung, TNQ, Taiwan
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 181 publications
Molecular epidemiology and emerging tet(X)-associated resistance of Elizabethkingia spp. in Taiwan, 2016-2022.
Journal: Antimicrobial agents and chemotherapy
Published: June 12, 2026
High-fold Homogeneous Expansion Microscopy Reveals Ultrastructural Centrioles.
Journal: ACS nano
Published: May 04, 2026
Correction: Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study.
Journal: Targeted oncology
Published: April 29, 2026
Consensus recommendations for the management of Dato-DXd-associated adverse events in patients with advanced/metastatic NSCLC: insights from a multiregional steering committee.
Journal: Therapeutic advances in medical oncology
Published: April 24, 2026
Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis.
Journal: Targeted oncology
Published: March 06, 2026
Adaptable centriole biogenesis via the intrinsically disordered protein ALMS1.
Journal: Nature communications
Published: February 10, 2026
A Pilot Study to Develop an Ultrasensitive Thio-NAD Cycling ELISA for Neisseria gonorrhoeae Detection.
Journal: Biological & pharmaceutical bulletin
Published: February 08, 2026
A Longitudinal Study of Antimicrobial Resistance in Oral Bacterial Isolates From Periodontitis Patients in Taiwan.
Journal: International dental journal
Published: February 02, 2026
The Importance of Driver-Targeted Therapy Among Patients With Lung Cancer Initially Diagnosed in the Intensive Care Unit.
Journal: Asia-Pacific journal of clinical oncology
Published: January 02, 2026
Outcomes associated with carbapenem-sparing versus carbapenem-containing therapy for third-generation cephalosporin non-susceptible Serratia marcescens bacteremia: a retrospective cohort analysis.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: December 28, 2025
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial.
Journal: Future oncology (London, England)
Published: December 18, 2025
Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study.
Journal: Targeted oncology
Published: December 05, 2025
Last Updated: 09/26/2026